Last 796.00 GBp
Change Today -1.00 / -0.13%
Volume 95.0K
BTG On Other Exchanges
Symbol
Exchange
London
Berlin
OTC US
As of 7:35 AM 12/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Guenter R. Janhofer

Chief Medical Officer and Head of Development, BTG plc
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

----

Background*

Dr. Guenter R. Janhofer has been Head of Development and Chief Medical Officer of BTG plc since joining in March 2009 and since 2011 Respectively. Mr. Janhofer has more than 25 years of experience in the pharmaceutical industry across all phases of clinical development from Phase I to end-stage life-cycle management and across a wide variety of therapeutic areas, including cardiovascular, metabolic, neuroscience, infectious diseases, respiratory, osteoporosis and oncology. ...

Read Full Background

Corporate Headquarters*

5 Fleet Place
London, Greater London EC4M 7RD

United Kingdom

Phone: 44 20 7575 0000
Fax: 44 20 7575 0010

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD
Ruhr-Universität Bochum
Bachelor's Degree
Technische Universität Berlin
MD
Universität Hamburg

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BTG:LN 796.00 GBp -1.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Fred P. Lampropoulos Chairman, Chief Executive Officer and President
Merit Medical Systems, Inc.
$887.7K
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
--
Aijaz Tobaccowalla Managing Director, Additional Director, Member of Board Administrative Committee and Member of Nomination & Remuneration Committee
Pfizer Limited
30.3M
Said Samih Taleb Darwazah Chairman and Chief Executive Officer
Hikma Pharmaceuticals plc
$2.4M
John A. Amster Co-Founder, Chief Executive Officer, President and Director
RPX Corporation
$700.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BTG PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.